部分原文报道如下９/div>
In accordance with Article 43 of Regulation (EC) 396/2005, EFSA received a request from the European Commission to review the existing maximum residue levels (MRLs) for the non-approved active substances azocyclotin and cyhexatin in view of the possible lowering of these MRLs. EFSA investigated the origin of the current EU MRLs. For existing EU MRLs that reflect previously authorised uses in the EU, or that are ba
sed on obsolete Codex Maximum Residue Limits, or im
port tolerances that are not required any longer, EFSA proposed the lowering to the limit of quantification. EFSA performed an indicative chro
nic and acute dietary risk assessment for the revised list of MRLs to allow risk managers to take the appropriate decisions. For some commodities under assessment, further risk management discussions are required to decide which of the risk management options proposed by EFSA should be implemented in the EU MRL legislation.
更多详情参见：https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2023.8038
本文由食品伙伴网食品资讯中心编辑，有任何疑问，请联系news@www.sqrdapp.com、/span>
相关政策解读
地区９/font>
欧盟评估转基因玉米MO
欧盟评估一种麦芽糖淀
美国拟撤销若干肉类叉/a>
鲁公网安 37060202000128叶/a>
